Viking Therapeutics (VKTX) News Today $55.06 -5.54 (-9.14%) (As of 11/13/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Viking Therapeutics (NASDAQ:VKTX) Shares Down 3.1% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Shares Down 3.1% - Should You Sell?November 13 at 3:49 PM | marketbeat.comDid Viking Therapeutics Just Say "Checkmate" To Eli Lilly?November 13 at 9:45 AM | fool.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by Chartwell Investment Partners LLCChartwell Investment Partners LLC lifted its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 88.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,666 shares of the biotechnology company's stock aNovember 13 at 4:55 AM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 5.6% - What's Next?Viking Therapeutics (NASDAQ:VKTX) Shares Down 5.6% - Here's What HappenedNovember 12 at 7:54 PM | marketbeat.comViking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024November 12 at 4:05 PM | prnewswire.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by Principal Financial Group Inc.Principal Financial Group Inc. boosted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 29.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 593,528 shares of the biotechnology coNovember 12 at 3:42 AM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 2.2% After Insider SellingViking Therapeutics (NASDAQ:VKTX) Stock Price Down 2.2% on Insider SellingNovember 11 at 11:35 AM | marketbeat.comIs Viking Therapeutics a Buy on the Dip?November 10 at 5:15 AM | fool.comLawson Macartney Sells 2,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) StockNovember 9, 2024 | insidertrades.comFiera Capital Corp Makes New $18.44 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Fiera Capital Corp acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 291,318 shares of the biotechnology company'sNovember 9, 2024 | marketbeat.comInsider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) Director Sells 2,000 Shares of StockViking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) Director Lawson Macartney sold 2,000 shares of the business's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $68.67, for a total transaction of $137,340.00. Following the completion of the sale, the director now owns 47,965 shares of the company's stock, valued at approximately $3,293,756.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.November 8, 2024 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 0.8% - What's Next?Viking Therapeutics (NASDAQ:VKTX) Trading Down 0.8% - Here's What HappenedNovember 8, 2024 | marketbeat.comHealthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZenecaNovember 8, 2024 | cnbc.comQuantum Private Wealth LLC Acquires 7,161 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Quantum Private Wealth LLC increased its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 84,084 shares of the biotechnology company's stock afterNovember 8, 2024 | marketbeat.com4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart MoveNovember 8, 2024 | fool.comViking Therapeutics (NASDAQ:VKTX) Price Target Raised to $102.00 at HC WainwrightNovember 8, 2024 | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Shares Up 0.3% - Time to Buy?Viking Therapeutics (NASDAQ:VKTX) Trading Up 0.3% - Should You Buy?November 7, 2024 | marketbeat.comGot $5,000? Viking Therapeutics Stock Just Got a Big New Green FlagNovember 7, 2024 | fool.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by AlphaCentric Advisors LLCAlphaCentric Advisors LLC decreased its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 78.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,500 shares of the biotechnology companyNovember 5, 2024 | marketbeat.comIs Viking Therepautics a Buy Now?November 5, 2024 | fool.comViking Therapeutics Stock Soars, Picks Up Retail Buzz On ‘Promising’ Early Results For Obesity PillNovember 5, 2024 | msn.comViking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And SafetyNovember 4, 2024 | finance.yahoo.comWhy Viking Therapeutics Stock Plummeted After Soaring TodayNovember 4, 2024 | fool.comHow does Viking's weight loss med compare to ones from Novo, Eli Lilly?November 4, 2024 | msn.comViking Therapeutics (VKTX) Gets a Buy from Stifel NicolausNovember 4, 2024 | markets.businessinsider.comViking Therapeutics (VKTX) Gets a Buy from Truist FinancialNovember 4, 2024 | markets.businessinsider.comViking Therapeutics stock falling amid results for new GLP-1 pillNovember 4, 2024 | finance.yahoo.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 8.7% - Time to Sell?Viking Therapeutics (NASDAQ:VKTX) Shares Down 8.7% - Here's WhyNovember 4, 2024 | marketbeat.comViking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial ResultsNovember 4, 2024 | investopedia.comViking Therapeutics: Too Much Excitement Around Oral VK2735, Even If It Met High ExpectationsNovember 4, 2024 | seekingalpha.comViking Therapeutics reports encouraging results from weightloss tabletNovember 4, 2024 | proactiveinvestors.comViking Therapeutics reports encouraging results from weightloss tabletNovember 4, 2024 | proactiveinvestors.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Up After Analyst UpgradeViking Therapeutics (NASDAQ:VKTX) Shares Gap Up Following Analyst UpgradeNovember 4, 2024 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for Viking Therapeutics (NASDAQ:VKTX) StockHC Wainwright lifted their price objective on shares of Viking Therapeutics from $90.00 to $102.00 and gave the company a "buy" rating in a research note on Monday.November 4, 2024 | marketbeat.comViking Therapeutics soars as early-stage oral obesity drug data exceeds expectationsNovember 4, 2024 | reuters.comViking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024November 4, 2024 | prnewswire.comViking shares jump after positive early data on oral obesity pill; Lilly, Novo dropNovember 4, 2024 | msn.comViking Therapeutics stock jumps after ‘great' trial of weight-loss drugNovember 4, 2024 | marketwatch.comViking Experimental Obesity Pill Shows Promise in Early StudyNovember 4, 2024 | bloomberg.comViking Therapeutics' Obesity Drug Data Shows Promising Early ResultsNovember 4, 2024 | markets.businessinsider.comViking Therapeutics Surges, Set To Break Out On Latest Obesity Drug DataNovember 3, 2024 | investors.comNvwm LLC Acquires New Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Nvwm LLC bought a new position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,784 shares of the biotechnology company's stock,November 3, 2024 | marketbeat.comMarketBeat Week in Review – 10/28 - 11/1 (VKTX)Stocks staged a strong rally on Friday following a steep sell-off; a weak jobs report all but guarantees a rate cut which adds to bullish sentimentNovember 2, 2024 | marketbeat.comOak Ridge Investments LLC Invests $837,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)Oak Ridge Investments LLC acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 13,222 shares of the biotechnology companNovember 2, 2024 | marketbeat.comViking Therapeutics to Participate at Upcoming Investor ConferencesOctober 31, 2024 | prnewswire.comUp 285% YTD, Is It Too Late to Buy This Biotech Stock?October 31, 2024 | msn.comViking Therapeutics Stock: A Pre-Election Bet Worth ConsideringViking Therapeutics is making headway in the weight loss drug market; but even though the payoff is years away, there's still plenty of upside for investorsOctober 31, 2024 | marketbeat.comViking Therapeutics CFO Cashes Out: $10M in Shares Sold Amidst Stock SurgeOctober 30, 2024 | finance.yahoo.comGreg Zante Sells 131,687 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) StockOctober 29, 2024 | insidertrades.comViking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024October 28, 2024 | prnewswire.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.510.55▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼2013▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Prothena News Today Puma Biotechnology News Today Marinus Pharmaceuticals News Today BioNTech News Today BeiGene News Today Moderna News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Viatris News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
